BR0007894A - Emprego de moxonidina para tratamento apósinfarto cardìaco - Google Patents

Emprego de moxonidina para tratamento apósinfarto cardìaco

Info

Publication number
BR0007894A
BR0007894A BR0007894-8A BR0007894A BR0007894A BR 0007894 A BR0007894 A BR 0007894A BR 0007894 A BR0007894 A BR 0007894A BR 0007894 A BR0007894 A BR 0007894A
Authority
BR
Brazil
Prior art keywords
treatment
moxonidine
myocardial infarction
cardiac infarction
infarction
Prior art date
Application number
BR0007894-8A
Other languages
English (en)
Inventor
Regina Gertruida Schoemaker
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of BR0007894A publication Critical patent/BR0007894A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Details Of Spanners, Wrenches, And Screw Drivers And Accessories (AREA)
  • Heat Treatment Of Articles (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

Patente de Invenção: "EMPREGO DE MOXONIDINA PARATRATAMENTO APóS INFARTO CARDìACO". é descrito oemprego de moxonidina e seus sais ácidos de adiçãofisiologicamente compatíveis para produção de preparaçõesfarmacêuticas para tratamento de danos do miocárdio causadospor infarto do miocárdio. Preparações farmacêuticas contendomoxonidina e seus sais ácidos de adição fisiologicamentecompatíveis, são apropriadas para emprego aqui tendo em vista otratamento do infarto agudo do miocárdio elou tratamentopós-infarto do miocárdio.
BR0007894-8A 1999-02-01 2000-01-28 Emprego de moxonidina para tratamento apósinfarto cardìaco BR0007894A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19903780 1999-02-01
PCT/EP2000/000655 WO2000045820A1 (de) 1999-02-01 2000-01-28 Verwendung von moxonidin zur behandlung nach herzinfarkt

Publications (1)

Publication Number Publication Date
BR0007894A true BR0007894A (pt) 2001-10-30

Family

ID=7895940

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007894-8A BR0007894A (pt) 1999-02-01 2000-01-28 Emprego de moxonidina para tratamento apósinfarto cardìaco

Country Status (26)

Country Link
US (1) US7041303B2 (pt)
EP (1) EP1150680B1 (pt)
JP (1) JP4686027B2 (pt)
KR (1) KR20010092793A (pt)
CN (1) CN1166363C (pt)
AT (1) ATE286731T1 (pt)
AU (1) AU774855B2 (pt)
BR (1) BR0007894A (pt)
CA (1) CA2361600C (pt)
CZ (1) CZ20012615A3 (pt)
DE (2) DE10003771A1 (pt)
DK (1) DK1150680T3 (pt)
ES (1) ES2235829T3 (pt)
HK (1) HK1042650B (pt)
HU (1) HUP0105210A3 (pt)
IL (1) IL144621A (pt)
NO (1) NO321061B1 (pt)
NZ (1) NZ513869A (pt)
PL (1) PL195124B1 (pt)
PT (1) PT1150680E (pt)
RU (1) RU2261097C2 (pt)
SK (1) SK10082001A3 (pt)
TR (1) TR200102221T2 (pt)
UA (1) UA67822C2 (pt)
WO (1) WO2000045820A1 (pt)
ZA (1) ZA200105827B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102850331B (zh) * 2012-09-17 2015-05-20 符爱清 一种化合物的制备方法
CN103483268B (zh) * 2013-09-17 2015-10-14 常州大学 一种4,6-二氯-2-甲基-5-硝基嘧啶的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739779A1 (de) * 1987-11-24 1989-06-08 Beiersdorf Ag Pharmazeutische praeparate
AU3233197A (en) * 1996-06-06 1998-01-05 Eli Lilly And Company Formulation and method for treating congestive heart failure

Also Published As

Publication number Publication date
KR20010092793A (ko) 2001-10-26
AU2440400A (en) 2000-08-25
DE50009220D1 (de) 2005-02-17
HUP0105210A2 (hu) 2002-05-29
IL144621A (en) 2004-12-15
UA67822C2 (uk) 2004-07-15
ZA200105827B (en) 2002-07-16
IL144621A0 (en) 2002-05-23
NZ513869A (en) 2001-09-28
EP1150680B1 (de) 2005-01-12
ES2235829T3 (es) 2005-07-16
HK1042650A1 (en) 2002-08-23
WO2000045820A1 (de) 2000-08-10
PL350559A1 (en) 2002-12-16
NO321061B1 (no) 2006-03-06
JP2002536334A (ja) 2002-10-29
CN1338938A (zh) 2002-03-06
CA2361600A1 (en) 2000-08-10
DK1150680T3 (da) 2005-03-07
TR200102221T2 (tr) 2002-01-21
HK1042650B (zh) 2005-05-06
NO20013753L (no) 2001-09-28
DE10003771A1 (de) 2000-08-03
PT1150680E (pt) 2005-03-31
SK10082001A3 (sk) 2002-04-04
EP1150680A1 (de) 2001-11-07
RU2261097C2 (ru) 2005-09-27
US20020045633A1 (en) 2002-04-18
PL195124B1 (pl) 2007-08-31
AU774855B2 (en) 2004-07-08
CA2361600C (en) 2008-08-26
HUP0105210A3 (en) 2003-01-28
CN1166363C (zh) 2004-09-15
ATE286731T1 (de) 2005-01-15
JP4686027B2 (ja) 2011-05-18
CZ20012615A3 (cs) 2002-01-16
NO20013753D0 (no) 2001-07-31
US7041303B2 (en) 2006-05-09

Similar Documents

Publication Publication Date Title
HUP0003173A2 (hu) A GLP-1 vagy analógjainak alkalmazása szívizominfarktus kezelésére használható gyógyszerkészítmények előállítására
SE8804629D0 (sv) New therapeutically active compounds
RU2002109240A (ru) Применение ретигабина для невропатических болей
ATE182581T1 (de) Metalloproteinase-inhibitoren
PT1227806E (pt) Formulacao farmaceutica contendo tolterodina e sua utilizacao
BRPI0008228B8 (pt) composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes
ATE322878T1 (de) Biotin enthaltende galenische formulierung
WO2001047913A3 (de) Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate antitumorwirkung
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
HUP0302288A2 (hu) Kardiális aritmiák kezelésében alkalmazható oxa-biszpidin-származék és az ezt tartalmazó gyógyszerkészítmények
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
NO912414L (no) Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling.
HUP9802897A2 (hu) Optikailag aktív piridil-4H-1,2,4-oxadiazin-származék, annak alkalmazása vaszkuláris betegségek kezelésére, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény
BR0007894A (pt) Emprego de moxonidina para tratamento apósinfarto cardìaco
RU2001120358A (ru) Применение ингибиторов натрий-водород-антипортера для получения лекарственного средства для ингибирования обусловленных возрастом дисфункций органов, обусловленных возрастом заболеваний и для продления жизни
HRP20050815A2 (en) 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound
AR026631A1 (es) ''3-4-dihidroquinazolinas 5,6-disustituidas''
BR0303384A (pt) Citalopram e seus usos no tratamento de pressão sanguìnea elevada
HUP0402118A2 (hu) Propionil-L-karnitin vagy gyógyászatilag elfogadható sója, alkalmazása peyronie-betegség kezelésére szánt gyógyászati készítmény előállítására
SE9902674D0 (sv) New composition
IT1279386B1 (it) 1,5 derivati di 7a-metilperidroinden-3a-oli, attivi sul sistema cardiovascolare, procedimenti per la loro preparazione e composizioni
AR003117A1 (es) El uso de derivado de aminotetralina para la preparacion de composiciones farmaceuticas para la terapia de enfermedades cardiovasculares y dichascomposiciones farmaceuticas.
TH51071A3 (th) ตัวยับยั้งเอนไซม์ย่อยสลายโปรตีน
RU2001123675A (ru) Средство бальзам "ГРААЛЬ" для лечения сердечно-сосудистой системы и заболеваний крови человека
RU2000105080A (ru) Препарат для лечения гриппа

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 31/506, C07D 403/12, A61P 9/10

Ipc: A61K 31/506 (2009.01), A61P 9/10 (2009.01)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIDO O PEDIDO COM BASE NOS ARTIGOS 8O, 13, 24 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25D Requested change of name of applicant approved

Owner name: ABBOTT PRODUCTS GMBH (DE)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 15A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2291 DE 02/12/2014.